High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy | SpringerLink
Principles of Immunosuppression in the Management of Kidney Disease: Core Curriculum 2022 - American Journal of Kidney Diseases
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative - The Lancet Rheumatology
Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations - eBioMedicine
The need for minimization strategies: current problems of immunosuppression - Bamoulid - 2015 - Transplant International - Wiley Online Library
Frontiers | Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
Frontiers | Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy | Nature Reviews Clinical Oncology
Cancers | Free Full-Text | Mechanisms of Immunosuppression in Colorectal Cancer | HTML
Severe and multifaceted systemic immunosuppression caused by experimental cancers of the central nervous system requires release of non-steroid soluble mediators | bioRxiv
JCM | Free Full-Text | Post-Transplant Cyclophosphamide and Tacrolimus—Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA ...
Frontiers | Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression
Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States | American Society of Nephrology
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative - The Lancet Rheumatology
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text
Tumor mutational burden and immunotherapy in gliomas: Trends in Cancer
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text
Frontiers | Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
PDF) Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden
Massive PD-L1 and CD8 double positive TILs characterize an immunosuppressive microenvironment with high mutational burden in lung cancer | Journal for ImmunoTherapy of Cancer
Immunosuppressive Therapy and Risk Stratification of Patients With Myocarditis Presenting With Ventricular Arrhythmias - ScienceDirect
The need for minimization strategies: current problems of immunosuppression - Bamoulid - 2015 - Transplant International - Wiley Online Library
Managing immunosuppressive therapy in potentially cured post‐kidney transplant cancer (excluding non‐melanoma skin cancer): an overview of the available evidence and guidance for shared decision‐making - Hellemans - 2021 - Transplant International -
Hypoxia-reprogrammed regulatory group 2 innate lymphoid cells promote immunosuppression in pancreatic cancer - eBioMedicine
